P POITEVIN
Overview
Explore the profile of P POITEVIN including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
516
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ben Driss A, Himbert C, POITEVIN P, Duriez M, Michel J, Levy B
J Cardiovasc Pharmacol
. 1999 Jul;
34(1):102-7.
PMID: 10413075
Systemic arterial elastic properties, important determinants of left ventricular function and coronary blood flow, are compromised in myocardial infarction (MI). The cardiac effect of angiotensin-converting enzyme inhibitors (ACEIs) has been...
2.
Sabri A, Samuel J, Marotte F, POITEVIN P, Rappaport L, Levy B
Hypertension
. 1998 Aug;
32(2):371-5.
PMID: 9719070
The long-lasting effect of angiotensin II (Ang II) on the microvasculature in the rat left ventricle was studied. Immunolabeling of ventricular cryosections combined with morphometric analysis allowed us to (1)...
3.
Lichtenstein O, Safar M, Mathieu E, POITEVIN P, Levy B
Hypertension
. 1998 Aug;
32(2):346-50.
PMID: 9719065
Several recent results obtained in hypertensive animals and subjects under in vivo isobaric conditions do not confirm the classic view of stiffer arteries in hypertensive subjects. We compared the mechanical...
4.
Breakers of advanced glycation end products restore large artery properties in experimental diabetes
Wolffenbuttel B, Boulanger C, Crijns F, Huijberts M, POITEVIN P, Swennen G, et al.
Proc Natl Acad Sci U S A
. 1998 May;
95(8):4630-4.
PMID: 9539789
Glucose and other reducing sugars react with proteins by a nonenzymatic, posttranslational modification process called nonenzymatic glycation. The formation of advanced glycation end products (AGEs) on connective tissue and matrix...
5.
Lacolley P, POITEVIN P, Koen R, Levy B
J Hypertens
. 1998 Apr;
16(3):349-55.
PMID: 9557928
Objective: To compare the effects of chronic administration of two dihydropyridines, nifedipine and amlodipine, and the non-dihydropyridine Ca2+ antagonist mibefradil on fluid filtration of large arteries and extravasation of albumin...
6.
Corman B, Duriez M, POITEVIN P, Heudes D, Bruneval P, Tedgui A, et al.
Proc Natl Acad Sci U S A
. 1998 Mar;
95(3):1301-6.
PMID: 9448326
Aging is associated with cardiac hypertrophy and arterial stiffening possibly associated with accumulation of advanced glycation end products (AGEs). We evaluated the effect of aminoguanidine, an inhibitor of AGE production,...
7.
Henrion D, Terzi F, Matrougui K, Duriez M, Boulanger C, Babinet C, et al.
J Clin Invest
. 1998 Feb;
100(11):2909-14.
PMID: 9389758
The intermediate filament vimentin might play a key role in vascular resistance to mechanical stress. We investigated the responses to pressure (tensile stress) and flow (shear stress) of mesenteric resistance...
8.
Dowell F, Benessiano J, POITEVIN P, Levy B, Henrion D
J Hypertens
. 1997 May;
15(5):523-9.
PMID: 9170005
Objective: To investigate the vasoactive properties of large (aorta) and small (mesenteric) arteries in vitro after chronic losartan treatment of normotensive rats, hence providing information on the role played by...
9.
Levy B, POITEVIN P, Duriez M, Guez D, Schiavi P, Safar M
J Hypertens
. 1997 Mar;
15(3):251-8.
PMID: 9468452
Background: Reduction in sodium intake improves the survival of stroke-prone spontaneously hypertensive rats (SHR-SP) without causing any change in their blood pressure. Objective: To investigate whether the diuretic indapamide improves...
10.
Ben Driss A, Benessiano J, POITEVIN P, Levy B, Michel J
Am J Physiol
. 1997 Feb;
272(2 Pt 2):H851-8.
PMID: 9124448
The effects of chronic increase in aortic blood flow on arterial wall remodeling were investigated in vivo with the use of an aortocaval fistula (ACF) model in rats. Phasic hemodynamics...